28 results
8-K
EX-99.5
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
products. Kineta may also experience delays in developing a sustainable, reproducible and scalable manufacturing process or transferring that process
424B3
KA
Kineta Inc
10 Nov 22
Prospectus supplement
4:21pm
, and/or developing new product candidates from Yumanity’s discovery engine platform;
developing a sustainable and scalable manufacturing process … of Kineta’s platform technologies may not ever result in marketable products. Kineta may also experience delays in developing a sustainable, reproducible
8-K/A
EX-99.1
tyiel8v h0uvmo
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.2
wsalqz
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.7
6klr 3hf7em9t
3 Feb 21
Other Events
4:59pm
424B3
ipcsi08mribkbj3n
12 Nov 20
Prospectus supplement
6:08am